Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 420 entries
View as:

Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00002592 Org: User:
Start: 06/30/93 End: 08/31/02 Due: 08/31/03

Proton Radiation for Chordomas and Chondrosarcomas

Phase: N/A Priority: Normal
NCT ID: NCT01449149 Org: User:
Start: 03/31/10 End: 12/31/26 Due: 12/31/27

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03546829 Org: User:
Start: 03/05/19 End: 12/31/27 Due: 12/31/28

Acute Effects of Cigarette Packaging and Charcoal Filtration on Perceptions, Use Behaviors, and Harm Exposure

Phase: N/A Priority: Normal
NCT ID: NCT05157048 Org: User:
Start: 03/10/22 End: 02/14/23 Due: 02/14/24

Indocyanine Green for Central Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02710240 Org: User:
Start: 06/10/15 End: 04/02/20 Due: 04/02/21

Penn Biobank Return of Research Results Program

Phase: N/A Priority: Normal
NCT ID: NCT04242667 Org: User:
Start: 03/01/20 End: 08/01/23 Due: 08/01/24

Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis

Phase: N/A Priority: Normal
NCT ID: NCT02769546 Org: User:
Start: 01/31/16 End: 01/31/18 Due: 01/31/19

Vaccine Responses in Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06605625 Org: User:
Start: 11/04/22 End: 10/31/28 Due: 10/31/29

HOPE: Olaparib, Palbociclib and Fulvestrant in Patients with BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03685331 Org: User:
Start: 10/15/20 End: 08/31/25 Due: 08/31/26

Improve Outcomes for Older Allogeneic Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT05612789 Org: User:
Start: 02/15/23 End: 11/01/26 Due: 11/01/27

APBI Proton Feasibility and Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT01839838 Org: User:
Start: 04/22/13 End: 12/23/22 Due: 12/23/23

Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710

Phase: N/A Priority: Normal
NCT ID: NCT02756637 Org: User:
Start: 04/30/16 End: 11/30/16 Due: 11/30/17

Proton Radiotherapy for Upper Gastrointestinal Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01449864 Org: User:
Start: 08/31/11 End: 12/31/19 Due: 12/31/20

RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04827862 Org: User:
Start: 07/01/22 End: 12/31/25 Due: 12/31/26

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05733715 Org: User:
Start: 05/03/23 End: 01/31/28 Due: 01/31/29

A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.

Phase: N/A Priority: Normal
NCT ID: NCT02277548 Org: User:
Start: 05/31/14 End: 04/30/18 Due: 04/30/19

A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01897116 Org: User:
Start: 06/30/13 End: 10/05/16 Due: 10/05/17

Cigar Packaging Study

Phase: N/A Priority: Normal
NCT ID: NCT04605874 Org: User:
Start: 03/05/20 End: 12/15/22 Due: 12/15/23

Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02316002 Org: User:
Start: 01/21/15 End: 12/31/22 Due: 12/31/23

MRI to Detect Breast Tumors in Women

Phase: N/A Priority: Normal
NCT ID: NCT00003302 Org: User:
Start: 05/31/98 End: 06/30/00 Due: 06/30/01

Proton Radiation For Meningiomas and Hemangiopericytomas

Phase: N/A Priority: Normal
NCT ID: NCT01117844 Org: User:
Start: 02/04/10 End: 03/31/23 Due: 03/31/24

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

Phase: N/A Priority: Normal
NCT ID: NCT05721326 Org: User:
Start: 05/01/23 End: 12/31/25 Due: 12/31/26

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients with Inherited Genetic Risk

Phase: N/A Priority: Normal
NCT ID: NCT02478892 Org: User:
Start: 05/31/15 End: 05/31/30 Due: 05/31/31

Physiologic MR Imaging of Salivary Gland Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04452162 Org: User:
Start: 08/25/20 End: 06/30/25 Due: 06/30/26

RADVAX™: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02880345 Org: User:
Start: 08/31/16 End: 12/31/18 Due: 12/31/19